PrEPARING ASIA 2025 report sets out priorities for equitable access to HIV prevention across Asia and the Pacific. Download APCOM Community Summit: PrEPARING ASIA 2025…
VanessSeptember 11, 2026
Prevention options, including both oral and injectable pre-exposure prophylaxis (PrEP), are central to HIV prevention in the Asia-Pacific region. Community-led organisations play an equally vital…
VanessOctober 30, 2025
APCOM welcomes the landmark agreement brokered by CHAI and UNITAID, which provides Dr. Reddy’s Laboratories with financial, technical, and regulatory support to deliver affordable, quality-assured…
VanessOctober 3, 2025
Bangkok, 22 May 2020 - APCOM welcomes the news of the HPTN 083 trail that evaluate the safety and efficacy of the injectable drug cabotegravir…
VanessMay 22, 2020
In September 2015, APCOM, together with multiple UN and other development agencies, co-organized “PrEParing Asia” – the region’s first community-led consultation to discuss with policymakers,…
Safir SoeparnaFebruary 27, 2017
APCOM with the support of UNAIDS, WHO, UNICEF, the USAID LINKAGES Project managed by FHI 360, UNDP and the Multi-Country South Asia Global Fund HIV…
Hidayah SyahputraJune 6, 2016
27 April 2016 (Bangkok) – Pre-exposure prophylaxis (PrEP), the daily medication that prevents HIV infections, is efficacious and has real potential to help global and…
ApcomApril 28, 2016
Sarmad Ali, a Youth Voices Count member from Pakistan, considers himself a PrEP advocate. With the grant from UNDP's Multi-Country South Asia Global Fund HIV Programme (based at…
ApcomNovember 1, 2015
Organized by APCOM with the support from UNAIDS and WHO, the dialogue brought in representatives of gay identified men, other men who have sex with men (MSM), sexual…
editorJuly 8, 2015
